Expansion Opportunity Althea has demonstrated growth with facility expansions in San Diego to support larger-scale GMP manufacturing and high potency products, signaling a potential need for additional scale-up capacity, process development support, or aseptic fill-finish capabilities for rising client projects.

Integrated CDMO As a fully integrated CDMO offering process development, drug substance and drug product manufacturing in a single location, Althea presents a compelling partner for clients seeking streamlined timelines, reduced risk, and single-source accountability across development to commercialization.

Aseptic Fill Finish Focus Althea’s specialization in drug formulation and aseptic fill finish for vials and syringes highlights a potential value area for clients needing robust sterile packaging capabilities, compatibility considerations, and regulatory-ready manufacturing for injectable therapies.

Clinical to Commercial With capacity to support early-stage clinical requirements through commercial manufacturing, there is an opportunity to engage with biotech companies transitioning programs from Phase I/II to late-stage trials and scale-up toward commercial launches.

San Diego Biotech Cluster Located in San Diego with recent facility investments, Althea is well-positioned to target regional biotech groups and adjacent biopharma partners seeking nearby, reliable CDMO services, potentially including collaborations on high-potency or specialized biologics programs.